Lung cancer and increase lactate dehydrogenases enzyme (LDH)

Background: The illness that poses the greatest threat to human health is still cancer. With almost 1.8 million occurrences per year, lung cancer continues to be the most common cause of cancer-related death globally. Lactate dehydrogenase (LDH), a housekeeping enzyme secreted by fast-developing tumors, is associated with tumor burden among all the possible blood indicators. According to our findings, there was a strong correlation between a high level of LDH prior to treatment and a bad prognosis. Therefore, for NSCLC patients receiving ICI treatment, a baseline blood LDH level may be utilized as a predictive biomarker. Tumor-immunoreactive factors are upregulated when lactic acid builds up. Shime et al. demonstrated that lactic acid increased interleukin-23 (IL-23) expression and production, which prevented CD8+ T cell infiltration in tumor microenvironments. Material and Methods: Between December 2019 and February 2021, thirty lung cancer patients visited International Baghdad Medical Hospital; thirty healthy individuals were selected as the healthy control groups. Using colorimeter and ELISA methods, the blood samples from these two study groups’ serum levels of lactate dehydrogenase enzyme (LDH) were determined. Results: There were thirty individuals with lung cancer in the study group. Thirty healthy volunteers who matched in terms of age and sex served as the control group. The difference between the serum lactate dehydrogenase levels of lung cancer patients and the healthy group is illustrated in Table 1 and Figure 1. The findings show that the serum lactate dehydrogenase percentage was 83.3%, significantly higher than the 16.7% threshold that is thought to be normal. Conclusion: The study demonstrates that measuring lactate dehydrogenase enzyme (LDH) levels is necessary to improve lung cancer patients’ prognosis. When compared to non-smokers, smokers lose at least ten years off their expected life expectancy. Giving up before the age of forty reduces the risk of smoking-related death by almost 90%.